Veterinary medicines European public assessment report (EPAR): Halagon, halofuginone, Status: Authorised
Q&A on impact of EU-USA Mutual Recognition Agreement on marketing authorisation applications and relevant variations - Revised 1st October 2025
Questions & Answers on the impact of Mutual Recognition Agreement (MRA) between the European Union and the United States as of 1st October 2025
Agenda of the CVMP meeting 7-9 October 2025
Finasteride / dutasteride
PSUSA/00002413/202502
PSUSA/00003129/202501
Human medicines European public assessment report (EPAR): Aplidin, plitidepsin, Status: Application withdrawn
Q&A clinic on web-based electronic application form (eAF) functionalities for CAPs and non-CAPs, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 September 2025, 15:00 (CEST) to 30 September 2025, 16:00 (CEST)
CAT: Working parties and other groups